254 related articles for article (PubMed ID: 18426823)
1. Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus.
van Deutekom AW; Niessen HW; Schalkwijk CG; Heine RJ; Simsek S
Eur J Endocrinol; 2008 May; 158(5):655-60. PubMed ID: 18426823
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
3. Elevated Nε-(carboxymethyl)lysine is associated with apoptosis of retinal pericytes in streptozotocin-induced diabetic rats.
Kim J; Kim CS; Sohn E; Kim JS
Ophthalmic Res; 2011; 46(2):92-7. PubMed ID: 21273798
[TBL] [Abstract][Full Text] [Related]
4. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
Meng J; Sakata N; Takebayashi S; Asano T; Futata T; Nagai R; Ikeda K; Horiuchi S; Myint T; Taniguchi N
Atherosclerosis; 1998 Feb; 136(2):355-65. PubMed ID: 9543107
[TBL] [Abstract][Full Text] [Related]
5. Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects.
Sebeková K; Krivošíková Z; Gajdoš M
Clin Chem Lab Med; 2014 Jan; 52(1):139-49. PubMed ID: 23509221
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
[TBL] [Abstract][Full Text] [Related]
8. Effect of N-epsilon-(carboxymethyl)lysine on coronary vasoconstriction in isolated perfused hearts from control and streptozotocin-induced diabetic rats.
Kamata K; Ozawa Y; Kobayashi T; Matsumoto T
J Smooth Muscle Res; 2009 Jun; 45(2-3):125-37. PubMed ID: 19602856
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats.
Salum E; Kals J; Kampus P; Salum T; Zilmer K; Aunapuu M; Arend A; Eha J; Zilmer M
Diabetes Res Clin Pract; 2013 May; 100(2):243-9. PubMed ID: 23522919
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end product in diabetic rat skeletal muscle in vivo.
Snow LM; Lynner CB; Nielsen EM; Neu HS; Thompson LV
Pathobiology; 2006; 73(5):244-51. PubMed ID: 17314495
[TBL] [Abstract][Full Text] [Related]
11. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
12. Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.
Sun M; Yokoyama M; Ishiwata T; Asano G
Int J Exp Pathol; 1998 Aug; 79(4):207-22. PubMed ID: 9797717
[TBL] [Abstract][Full Text] [Related]
13. Influence of insulin and muscle fiber type in nepsilon-(carboxymethyl)-lysine accumulation in soleus muscle of rats with streptozotocin-induced diabetes mellitus.
Snow LM; Thompson LV
Pathobiology; 2009; 76(5):227-34. PubMed ID: 19816082
[TBL] [Abstract][Full Text] [Related]
14. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
[TBL] [Abstract][Full Text] [Related]
15. Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.
Engelen L; Persson F; Ferreira I; Rossing P; Hovind P; Teerlink T; Stehouwer CD; Parving HH; Schalkwijk CG
Nephrol Dial Transplant; 2011 Nov; 26(11):3573-7. PubMed ID: 21385863
[TBL] [Abstract][Full Text] [Related]
16. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats.
Stracke H; Hammes HP; Werkmann D; Mavrakis K; Bitsch I; Netzel M; Geyer J; Köpcke W; Sauerland C; Bretzel RG; Federlin KF
Exp Clin Endocrinol Diabetes; 2001; 109(6):330-6. PubMed ID: 11571671
[TBL] [Abstract][Full Text] [Related]
18. AGEs, macrophage colony stimulating factor and vascular adhesion molecule blood levels are increased in patients with diabetic microangiopathy.
Wautier MP; Boulanger E; Guillausseau PJ; Massin P; Wautier JL
Thromb Haemost; 2004 May; 91(5):879-85. PubMed ID: 15116247
[TBL] [Abstract][Full Text] [Related]
19. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients.
Wautier MP; Massin P; Guillausseau PJ; Huijberts M; Levy B; Boulanger E; Laloi-Michelin M; Wautier JL
Diabetes Metab; 2003 Feb; 29(1):44-52. PubMed ID: 12629447
[TBL] [Abstract][Full Text] [Related]
20. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
